192 related articles for article (PubMed ID: 28472358)
1. Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.
Temporal KH; Scott KS; Mohr ALA; Logan BK
J Anal Toxicol; 2017 Sep; 41(7):646-657. PubMed ID: 28472358
[TBL] [Abstract][Full Text] [Related]
2. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
[TBL] [Abstract][Full Text] [Related]
3. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry.
Seo H; Kim IS; Kim YH; Yoo HH; Hong J
Int J Legal Med; 2019 May; 133(3):833-841. PubMed ID: 30090972
[TBL] [Abstract][Full Text] [Related]
5. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
6. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
[TBL] [Abstract][Full Text] [Related]
7. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
8. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
Zuba D; Sekuła K
Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
Yeter O; Ozturk YE
Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Fate of Hallucinogenic NBOMes.
Leth-Petersen S; Gabel-Jensen C; Gillings N; Lehel S; Hansen HD; Knudsen GM; Kristensen JL
Chem Res Toxicol; 2016 Jan; 29(1):96-100. PubMed ID: 26669514
[TBL] [Abstract][Full Text] [Related]
13. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.
Nielsen LM; Holm NB; Leth-Petersen S; Kristensen JL; Olsen L; Linnet K
Drug Test Anal; 2017 May; 9(5):671-679. PubMed ID: 27400739
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
[TBL] [Abstract][Full Text] [Related]
16. Metabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases.
Ameline A; Greney H; Monassier L; Raul JS; Kintz P
J Anal Toxicol; 2019 May; 43(4):321-324. PubMed ID: 30476158
[TBL] [Abstract][Full Text] [Related]
17. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
[TBL] [Abstract][Full Text] [Related]
18. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
19. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
[TBL] [Abstract][Full Text] [Related]
20. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.
Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL
Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]